Lyn

It can't hurt to ask them what actual evidence they have that Erbitux as a single agent chemotherapy is as effective as platinum based ones for HPV positive tumors. Don't let them confuse the issue with the Extreme trial which showed that Erbitux has great promise as an "add-on" or booster to platinum chemo. That's not the same as working solo. Also you may have to remind them gently that the Bonner study did not even take HPV into account at all.
Charm